wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37222790-3D9AF475-9DA6-4672-868A-F28B2DAED21C
Q37222790-3D9AF475-9DA6-4672-868A-F28B2DAED21C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37222790-3D9AF475-9DA6-4672-868A-F28B2DAED21C
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.
P356
Q37222790-3D9AF475-9DA6-4672-868A-F28B2DAED21C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37222790-3D9AF475-9DA6-4672-868A-F28B2DAED21C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c6c36b379cf681577c1b7a3df82f6bf31489c1a
P356
10.1007/S10637-016-0370-7
http://www.w3.org/2001/XMLSchema#string
P356
S10637-016-0370-7